GlassScriptPhysician profile
Rohan Adiga
NPI 1811511447
$2,988.26
in general payments reported to CMS, 2019-2025
7 companies · $936 in 2025
The $936 reported for 2025 was more than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $2,052 · 2025: $936.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $1,333 · Food and Beverage: $1,267 · Travel and Lodging: $220 · Education: $168.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $1,333.33 |
| Food and Beverage | $1,267.44 |
| Travel and Lodging | $219.70 |
| Education | $167.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,449.75 | 2024-2025 | Synchromedii, Inceptiv |
| Abbott Laboratories | $927.45 | 2024-2025 | Proclaim, Eterna |
| Boston Scientific Corporation | $239.11 | 2025 | Intracept, General - Pain Management |
| Biotronik Nro, INC. | $123.92 | 2025 | Prospera |
| Nalu Medical, INC. | $117.03 | 2024 | Nalu Neurostimulation System |
| Avanos Medical | $116.56 | 2025 | Generator |
| Spinal Simplicity, LLC | $14.44 | 2025 | Ha Minuteman G3-R |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rohan Adiga listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.